Literature DB >> 21168639

Liver recipient survival rate before and after model for end-stage liver disease implementation and use of donor risk index.

H O Manduca Palmiero1, P Kajikawa, I F S F Boin, S Coria, L A Pereira.   

Abstract

BACKGROUND: The progressive increase in the demand for liver transplantation has led to changes in donor selection and allocation, such as the Model for End-Stage Liver Disease Score (MELD). Characteristics related to the donor, recipient, and transplantation procedure influence the results. The use of expanded-criteria donors (ECDs) and the donor risk index (DRI) are strategies that have been proposed to increase the donors pool.
OBJECTIVE: We sought to study liver recipient survival before and after MELD implementation as well as the use of DRI.
METHODS: This retrospective study of prospectively collected data analyzed 1,786 liver recipients and their donors according to gender, age, cause of brain death, intensive care unit time, split liver, infection, ECD, cardiac arrest, cold ischemia time, waiting list time, and donor origin. MELD (without special scoring) and DRI were calculated from the recorded data. The periods of this study were 2004-2006 (pre-MELD) and 2006-2008 (post-MELD). For survival times, we performed the Kaplan-Meier method with log-rank tests and Cox regression analysis (prediction). The Kolmogorov-Sminorv test was used for sample comparisons.
RESULTS: The 1-year survivals were similar in the 2 periods (65.4% vs 67.6%). The predictive factors for death among the whole population were DRI >1.5, cold ischemia time ≥9 hours, MELD ≥25, female recipient, and longer waiting list time.
CONCLUSIONS: MELD is an important tool for allocation, resulting in a reduced waiting list, increased number of split-liver procedures, and use of ECDs without deterioration of survival times. DRI >1.7 was associated with shorter survival.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21168639     DOI: 10.1016/j.transproceed.2010.09.092

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

Review 1.  Model for end-stage liver disease: end of the first decade.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Clin Liver Dis       Date:  2011-10-01       Impact factor: 6.126

Review 2.  Model for end-stage liver disease score and MELD exceptions: 15 years later.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Hepatol Int       Date:  2015-05-28       Impact factor: 6.047

3.  Donor risk index predicts graft failure reliably but not post-transplant infections.

Authors:  Laura H Rosenberger; Jacob R Gillen; Tjasa Hranjec; Jayme B Stokes; Kenneth L Brayman; Sean C Kumer; Timothy M Schmitt; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2013-11-27       Impact factor: 2.150

4.  Decision making in liver transplantation--limited application of the liver donor risk index.

Authors:  Leslie Mataya; Andrew Aronsohn; J Richard Thistlethwaite; Lainie Friedman Ross
Journal:  Liver Transpl       Date:  2014-07       Impact factor: 5.799

5.  BAR, SOFT AND DRI POST-HEPATIC TRANSPLANTATION: WHAT IS THE BEST FOR SURVIVAL ANALYSIS?

Authors:  Fernando Torterolli; Rafael Katsunori Watanabe; Fernando Issamu Tabushi; Igor Luna Peixoto; Paulo Afonso Nunes Nassif; Nertan Luiz Tefilli; Sergio Luiz Rocha; Osvaldo Malafaia
Journal:  Arq Bras Cir Dig       Date:  2021-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.